Back to CBIO

Fairmount Funds Management LLC → CBIO

Fairmount Funds Management LLC CBIO Position History

Crescent Biopharma, Inc. • Healthcare

Quarters held
4
Latest value
$52.5M
Q3 2026
Peak value
$52.5M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$32.6M
Q1 2026$50.5M
Q2 2026$49.5M
Q3 2026$52.5M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$52.5M3.60M——
Q2 2026$49.5M2.75M——
Q1 2026$50.5M2.75M——
Q4 2025$32.6M2.75M——

Other funds holding CBIO

Other Fairmount Funds Management LLC positions

ORKA

ORUKA THERAPEUTICS INC

$352.6M
COGT

COGENT BIOSCIENCES INC

$319.8M
ORKA

ORUKA THERAPEUTICS INC

$308.6M
KRSA

KORSANA BIOSCIENCES INC

$291.3M
DNTH

DIANTHUS THERAPEUTICS INC

$247.3M
DNTH

DIANTHUS THERAPEUTICS INC

$223.4M
COGT

COGENT BIOSCIENCES INC

$213M
DNTH

DIANTHUS THERAPEUTICS INC

$212.9M